General discussion, page-349

First 349 Last

Share
Profile

Follow
dalts66

4,655 Posts.

2152

21/05/20

16:52

Post #: 44756929
Share

Originally posted by dalts66: ↑

I have no idea if its related to the IHL trial, but two other trials using the same drug as IHL, one in the USA and another in France, have been delayed to allow greater research into why a small trial in Brazil needed to be stopped.

“Hydroxychloroquine, which is available as a generic drug and is also produced under the brand name Plaquenil by French drugmaker Sanofi, can have serious side effects, including muscle weakness and heart arrhythmia. A small study in Brazil was halted for safety reasons after coronavirus patients taking chloroquine, which hydroxychloroquine is derived from, developed arrhythmia, including some who died.”

The FDA have put out an update re the drugs use, highlighting the side effects.

Expand

BBC News - Coronavirus: Hydroxychloroquine trial begins in the UK
https://www.bbc.co.uk/news/health-52737169

Hydroxychloroquine trials up and running.

IHL Price at posting: 5.1¢ Sentiment: Buy Disclosure: Held
2 Upvote

1 Great analysis

Reply

Top Stories

AVM

'Sure to be busy': Advance's Yuquivo drilling gets off to top start with first-hole hits

HotCopper Highlights, Week 24: Israel boosts Energy; Meeka eyes production & Mag7 back

Week 24 Wrap: WW3 looms (again); US econ data tepid & silver surfing

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

Zip's stunning comeback: Is this the start of a $14 revival?

There are more pages in this discussion • 137 more messages in this thread...

First 349 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

General discussion, page-349

Top Stories

'Sure to be busy': Advance's Yuquivo drilling gets off to top start with first-hole hits

HotCopper Highlights, Week 24: Israel boosts Energy; Meeka eyes production & Mag7 back

Week 24 Wrap: WW3 looms (again); US econ data tepid & silver surfing

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

Zip's stunning comeback: Is this the start of a $14 revival?

Featured News